Disparities in access to deep brain stimulation surgery for parkinson disease: Interaction between African American race and medicaid use

JAMA Neurology

Volumn 71, Issue 3, 2014, Pages 291-299

  Chan, Andrew K ^a   McGovern, Robert A ^a   Brown, Lauren T ^a   Sheehy, John P ^a,c   Zacharia, Brad E ^a   Mikell, Charles B ^a   Bruce, Samuel S ^a   Ford, Blair ^b   McKhann II, Guy M ^a  

^a NEUROLOGICAL INSTITUTE   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE; AGED; AMERICAN INDIAN; ARTICLE; ASIAN; BRAIN DEPTH STIMULATION; CAUCASIAN; CLINICAL FEATURE; COMORBIDITY; DEMOGRAPHY; FEMALE; HEALTH CARE ACCESS; HEALTH CARE DISPARITY; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HISPANIC; HOSPITAL BED CAPACITY; HOSPITAL DISCHARGE; HUMAN; ICD-9; IMPLANTABLE NEUROSTIMULATOR; INCOME; MAJOR CLINICAL STUDY; MALE; MEDICAID; NEGRO; NEUROLOGIST; PACIFIC ISLANDER; PARKINSON DISEASE; PREDICTION; PRIORITY JOURNAL; RACE DIFFERENCE; REGRESSION ANALYSIS; SEX RATIO; SOCIAL STATUS; SURGEON; TEACHING HOSPITAL; UNITED STATES; URBAN RURAL DIFFERENCE; VERY ELDERLY;

AFRICAN AMERICANS; AGE FACTORS; AGED; AGED, 80 AND OVER; DEEP BRAIN STIMULATION; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HUMANS; MALE; MEDICAID; MIDDLE AGED; PARKINSON DISEASE; SEX FACTORS; UNITED STATES;

EID: 84896780915     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2013.5798     Document Type: Article

References (49)

1. Fabbrini G, Brotchie JM, Grandas F, Nomoto M, Goetz CG. Levodopa-induced dyskinesias. Mov Disord. 2007; 22(10): 1379-1389, quiz 1523.
2. Deuschl G, Schade-Brittinger C, Krack P, et al; German Parkinson Study Group, Neurostimulation Section. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med. 2006; 355(9): 896-908.
3. Weaver FM, Follett K, Stern M, et al; CSP 468 Study Group. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA. 2009; 301(1): 63-73.
4. Williams A, Gill S, Varma T, et al; PD SURG Collaborative Group. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol. 2010; 9(6): 581-591.
5. Schuepbach WM, Rau J, Knudsen K, et al; EARLYSTIM Study Group. Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med. 2013; 368(7): 610-622.
6. Pilitsis JG, Burrows A, Peters ML, Sargent J, Ng SC, Tseng JF. Changing practice patterns of deep brain stimulation in Parkinson's disease and essential tremor in the USA. Stereotact Funct Neurosurg. 2012; 90(1): 25-29.
7. Eskandar EN, Flaherty A, Cosgrove GR, Shinobu LA, Barker FG II. Surgery for Parkinson disease in the United States, 1996 to 2000: practice patterns, short-term outcomes, and hospital charges in a nationwide sample. J Neurosurg. 2003; 99(5): 863-871.
8. Kessler II. Epidemiologic studies of Parkinson's disease, II: a hospital-based survey. Am J Epidemiol. 1972; 95(4): 308-318.
9. Kessler II. Epidemiologic studies of Parkinson's disease, 3: a community-based survey. Am J Epidemiol. 1972; 96(4): 242-254.
10. Mayeux R, Marder K, Cote LJ, et al. The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. Am J Epidemiol. 1995; 142(8): 820-827.
11. Schoenberg BS, Anderson DW, Haerer AF. Prevalence of Parkinson's disease in the biracial population of Copiah County, Mississippi. Neurology. 1985; 35(6): 841-845.
12. Van Den Eeden SK, Tanner CM, Bernstein AL, et al. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol. 2003; 157(11): 1015-1022.
13. Dahodwala N, Siderowf A, Xie M, Noll E, Stern M, Mandell DS. Racial differences in the diagnosis of Parkinson's disease. Mov Disord. 2009; 24(8): 1200-1205.
14. Burneo JG, Black L, Knowlton RC, Faught E, Morawetz R, Kuzniecky RI. Racial disparities in the use of surgical treatment for intractable temporal lobe epilepsy. Neurology. 2005; 64(1): 50-54.
15. McClelland S III, Guo H, Okuyemi KS. Racial disparities in the surgical management of intractable temporal lobe epilepsy in the United States: a population-based analysis. Arch Neurol. 2010; 67(5): 577-583.
16. Farjah F, Wood DE, Yanez ND III, et al. Racial disparities among patients with lung cancer who were recommended operative therapy. Arch Surg. 2009; 144(1): 14-18.
17. Freedman RA, He Y, Winer EP, Keating NL. Trends in racial and age disparities in definitive local therapy of early-stage breast cancer. J Clin Oncol. 2009; 27(5): 713-719.
18. Haas JS, Brawarsky P, Iyer A, Fitzmaurice GM, Neville BA, Earle C. Association of area sociodemographic characteristics and capacity for treatment with disparities in colorectal cancer care and mortality. Cancer. 2011; 117(18): 4267-4276.
19. Hardy D, Liu CC, Xia R, et al. Racial disparities and treatment trends in a large cohort of elderly black and white patients with nonsmall cell lung cancer. Cancer. 2009; 115(10): 2199-2211.
20. Mukherjee D, Zaidi HA, Kosztowski T, et al. Disparities in access to neuro-oncologic care in the United States. Arch Surg. 2010; 145(3): 247-253.
21. Mukherjee D, Zaidi HA, Kosztowski T, et al. Predictors of access to pituitary tumor resection in the United States, 1988-2005. Eur J Endocrinol. 2009; 161(2): 259-265.
22. Yu JC, Neugut AI, Wang S, et al. Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma. Cancer. 2010; 116(7): 1801-1809.
23. Overview of the Nationwide Inpatient Sample (NIS): 2002-2009. Healthcare Cost and Utilization Project (HCUP) website. http://www.hcup-us.ahrq.gov/ nisoverview.jsp. Accessed October 9, 2012.
24. Temlett JA, Thompson PD. Reasons for admission to hospital for Parkinson's disease. Intern Med J. 2006; 36(8): 524-526.
25. Area Resource Files (ARF). 2011-2012. US Department of Health and Human Services, Health Resources and Services Administration, Bureau of Health Professions website. http://arf.hrsa.gov/. Accessed October 9, 2012.
26. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998; 36(1): 8-27.
27. Dahodwala N, Xie M, Noll E, Siderowf A, Mandell DS. Treatment disparities in Parkinson's disease. Ann Neurol. 2009; 66(2): 142-145.
28. Cheng EM, Siderowf AD, Swarztrauber K, et al. Disparities of care in veterans with Parkinson's disease. Parkinsonism Relat Disord. 2008; 14(1): 8-14.
29. NINDS NET-PD Investigators. A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease. Neurology. 2006; 66(5): 664-671.
30. NINDS NET-PD Investigators. A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease. Neurology. 2007; 68(1): 20-28.
31. Schneider MG, Swearingen CJ, Shulman LM, Ye J, Baumgarten M, Tilley BC. Minority enrollment in Parkinson's disease clinical trials. Parkinsonism Relat Disord. 2009; 15(4): 258-262.
32. Cook ED, Moody-Thomas S, Anderson KB, et al. Minority recruitment to the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Clin Trials. 2005; 2(5): 436-442.
33. Wendler D, Kington R, Madans J, et al. Are racial and ethnic minorities less willing to participate in health research? PLoS Med. 2006; 3(2): e19.
34. McGovern RA, Sheehy JP, Zacharia BE, Chan AK, Ford B, McKhann GM II. Unchanged safety outcomes in deep brain stimulation surgery for Parkinson disease despite a decentralization of care. J Neurosurg. 2013; 119(6): 1546-1555.
35. Lin N, Popp AJ. Insurance status and patient outcome after neurosurgery. World Neurosurg. 2011; 76(5): 398-400.
36. Englot DJ, Ouyang D, Garcia PA, Barbaro NM, Chang EF. Epilepsy surgery trends in the United States, 1990-2008. Neurology. 2012; 78(16): 1200-1206.
37. Wang EC, Choe MC, Meara JG, Koempel JA. Inequality of access to surgical specialty health care: why children with government-funded insurance have less access than those with private insurance in Southern California. Pediatrics. 2004; 114(5): e584-e590.
38. Calfee RP, Shah CM, Canham CD, Wong AH, Gelberman RH, Goldfarb CA. The influence of insurance status on access to and utilization of a tertiary hand surgery referral center. J Bone Joint Surg Am. 2012; 94(23): 2177-2184.
39. National Coverage Determination (NCD) for Deep Brain Stimulation for Essential Tremor and Parkinson's disease (160.24). Centers for Medicare & Medicaid Services website. http://www.cms.gov/medicare-coverage-database/ details/ncd-details.aspx?NCDId=279&ncdver. Accessed October 19, 2013.
40. Figaro MK, Russo PW, Allegrante JP. Preferences for arthritis care among urban African Americans: "I don't want to be cut." Health Psychol. 2004; 23(3): 324-329.
41. Wenzel J, Jones R, Klimmek R, Szanton S, Krumm S. Exploring the role of community health workers in providing cancer navigation: perceptions of African American older adults. Oncol Nurs Forum. 2012; 39(3): 288-298.
42. Holt CL, Lukwago SN, Kreuter MW. Spirituality, breast cancer beliefs and mammography utilization among urban African American women. J Health Psychol. 2003; 8(3): 383-396.
43. Chornokur G, Dalton K, Borysova ME, Kumar NB. Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer. Prostate. 2011; 71(9): 985-997.
44. Saffar D, Williams K, Lafata JE, Divine G, Pladevall M. Racial disparities in lipid control in patients with diabetes. Am J Manag Care. 2012; 18(6): 303-311.
45. Kim G, Ford KL, Chiriboga DA, Sorkin DH. Racial and ethnic disparities in healthcare use, delayed care, and management of diabetes mellitus in older adults in California. J Am Geriatr Soc. 2012; 60(12): 2319-2325.
46. Vina ER, Cloonan YK, Ibrahim SA, Hannon MJ, Boudreau RM, Kwoh CK. Race, sex, and total knee replacement consideration: role of social support. Arthritis Care Res (Hoboken). 2013; 65(7): 1103-1111.
47. Demirovic J, Prineas R, Loewenstein D, et al. Prevalence of dementia in three ethnic groups: the South Florida program on aging and health. Ann Epidemiol. 2003; 13(6): 472-478.
48. Tang MX, Stern Y, Marder K, et al. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA. 1998; 279(10): 751-755.
49. Katz M, Kilbane C, Rosengard J, Alterman RL, Tagliati M. Referring patients for deep brain stimulation: an improving practice. Arch Neurol. 2011; 68(8): 1027-1032.